Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009325
Filing Date
2025-05-08
Accepted
2025-05-08 17:29:46
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 782464
2 ex31-1.htm EX-31.1 10088
3 ex31-2.htm EX-31.2 10083
4 ex32-1.htm EX-32.1 5086
5 ex32-2.htm EX-32.2 5122
  Complete submission text file 0001641172-25-009325.txt   5451659

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE shph-20250331.xsd EX-101.SCH 39254
7 XBRL CALCULATION FILE shph-20250331_cal.xml EX-101.CAL 52850
8 XBRL DEFINITION FILE shph-20250331_def.xml EX-101.DEF 230871
9 XBRL LABEL FILE shph-20250331_lab.xml EX-101.LAB 392443
10 XBRL PRESENTATION FILE shph-20250331_pre.xml EX-101.PRE 338965
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 728615
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41488 | Film No.: 25927552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)